Robert E. Hoffman is an accomplished executive and board member in the biotechnology sector, currently serving as President and Chief Executive Officer of Kintara Therapeutics, Inc. since 2021. Hoffman has held multiple board positions, including roles at Kura Oncology, Inc., and CombiMatrix Diagnostics, while also serving as Chief Financial Officer at Heron Therapeutics, Inc. from 2017 to 2020. Additionally, they are actively involved with various organizations, including TuHURA Biosciences and CytoDyn. Hoffman earned their education from St. Bonaventure University, where they studied from 1984 to 1988.
This person is not in the org chart
This person is not in any teams
This person is not in any offices